tradingkey.logo
tradingkey.logo
Buscar

Fortrea Holdings Inc

FTRE
Añadir a la lista de seguimiento
17.580USD
0.0000.00%
Cierre 07/01, 16:00ETCotizaciones retrasadas 15 min
1.66BCap. mercado
PérdidaP/E TTM

Más Datos de Fortrea Holdings Inc Compañía

Fortrea Holdings Inc. is a global contract research organization (CRO), which provides clinical development solutions to the life sciences industry. The Company is engaged in providing biopharmaceutical product and medical device development services to pharmaceutical, biotechnology and medical device customers. The Company offers customers flexible delivery models that include full service, functional service provider, and hybrid service structures. It provides phase I-IV clinical trial management, clinical pharmacology and consulting services. The Company manages its business through a single segment, Clinical Services, that provides services across the clinical pharmacology and clinical development spectrum. The Company has access to all key markets worldwide through a footprint of primary office locations in five countries (the United States, the United Kingdom, China, India and Singapore) with field operations in other jurisdictions worldwide.

Información de Fortrea Holdings Inc

Símbolo de cotizaciónFTRE
Nombre de la empresaFortrea Holdings Inc
Fecha de salida a bolsaJun 16, 2023
Director ejecutivoThakrala (Anshul)
Número de empleados15500
Tipo de seguridadOrdinary Share
Fin del año fiscalJun 16
Dirección8 Moore Drive
CiudadDURHAM
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal27709
Teléfono18774950816
Sitio Webhttps://www.fortrea.com/
Símbolo de cotizaciónFTRE
Fecha de salida a bolsaJun 16, 2023
Director ejecutivoThakrala (Anshul)

Ejecutivos de Fortrea Holdings Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Chairman of the Board
Chairman of the Board
246.67K
+60.22%
Dr. Amrit Ray, M.D.
Dr. Amrit Ray, M.D.
Lead Independent Director
Lead Independent Director
91.27K
+42.53%
Mr. Edward A. Pesicka
Mr. Edward A. Pesicka
Independent Director
Independent Director
91.27K
+42.53%
Ms. Machelle Sanders
Ms. Machelle Sanders
Independent Director
Independent Director
84.92K
+45.71%
Mr. David Ross Smith
Mr. David Ross Smith
Independent Director
Independent Director
68.93K
+29.84%
Ms. Jill Mcconnell
Ms. Jill Mcconnell
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Mark Morais
Mr. Mark Morais
Chief Operating Officer and President - Clinical Services
Chief Operating Officer and President - Clinical Services
--
--
Ms. Hima B. Inguva
Ms. Hima B. Inguva
Investor Relations
Investor Relations
--
--
Ms. Erin L. Russell
Ms. Erin L. Russell
Independent Director
Independent Director
--
--
Mr. Anshul Thakrala
Mr. Anshul Thakrala
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Chairman of the Board
Chairman of the Board
246.67K
+60.22%
Dr. Amrit Ray, M.D.
Dr. Amrit Ray, M.D.
Lead Independent Director
Lead Independent Director
91.27K
+42.53%
Mr. Edward A. Pesicka
Mr. Edward A. Pesicka
Independent Director
Independent Director
91.27K
+42.53%
Ms. Machelle Sanders
Ms. Machelle Sanders
Independent Director
Independent Director
84.92K
+45.71%
Mr. David Ross Smith
Mr. David Ross Smith
Independent Director
Independent Director
68.93K
+29.84%
Ms. Jill Mcconnell
Ms. Jill Mcconnell
Chief Financial Officer
Chief Financial Officer
--
--

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de Fortrea Holdings Inc?

Los cinco principales accionistas de Fortrea Holdings Inc son: Mr. Peter M. Neupert

¿Cuántas instituciones poseen acciones de Fortrea Holdings Inc (FTRE)?

A fecha de 2026Q1, 881 instituciones poseen acciones de Fortrea Holdings Inc, con un valor de mercado combinado de aproximadamente 98.32M, lo que representa el 103.93% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -25178846.00.